Developed Countries

Special Report

The old cyclical market axiom that "nothing cures low prices like low prices" has never held
truer than in today's oil market.

The rally in risk assets could persist. Dollar and oil moves are not yet exhausted. But valuations and poor earnings quality warrant a cautious approach.

For the month of March, the model outperformed both global and U.S. equities in U.S. dollar terms. For April, the model has further pared back its equity risk exposure, shifting the allocation into cash. While Europe remains the largest equity overweight, there was a modest recalibration to defensive markets such as the U.S. and Switzerland. The allocation to EM was also nudged up a bit, on momentum and valuation grounds. In the fixed-income space, the model is sticking with U.S., Italian and Spanish paper.

Special Report

There is little evidence suggesting that declining productivity growth in recent years has resulted from measurement error. Businesses have plucked many of the low-hanging fruits made possible by the IT revolution, while cyclical factors stemming from the Great Recession have also weighed on productivity. Low productivity growth tends to be deflationary in the short run, but inflationary longer-term. For now, this is good news for bonds, but is likely to become bad news by decade-end.

The British pound may be prone to further weakness in the coming months as the odds of a Brexit rise.

The S&P pharmaceutical index has checked back relative to the broad market, reflecting the powerful short covering and relief rally in higher beta sectors in recent weeks. While this trend may persist in the very near run, we expect relative performance to follow relative forward earnings growth. On this front, conditions are bullish. In absolute terms, pharmaceutical companies are enjoying a productivity revival, as a demand-driven surge in pricing power is underway. That stands in marked contrast with the rest of the corporate sector, which is battling deflation, as evidenced by the relentless decline in bond yields (shown inverted, top panel). The chart shows that when firms are cutting selling prices, pharmaceutical profits outperform, as is currently the case. Moreover, drug companies continue to use excess capital in a shareholder-friendly manner, as shares outstanding continue to sink. The bottom line is that pharmaceutical earnings are on track for further outperformance, which should pull up the share price ratio. Stay overweight. The ticker symbols for the stocks in this index are: AGN, BMY, LLY, ENDP, JNJ, MNK, MRK, MYL, PRGO, PFE, ZTS.

Airline stocks have enjoyed some modest relief in recent weeks, but we expect this resilience to fully reverse. The main issue is overcapacity. Discretionary spending is under pressure, based on the message from global manufacturing woes and the plunge in the National Association of Restaurants survey (second panel). Airlines have been aggressively building capacity, as evidenced by the increase in airline capital spending. Long airplane production cycles mean there is a lag between spending and when new capacity will come on stream, and the tripling in airline parts & components inventory in the last eight years warns that the delivery pipeline remains full. Airlines are already resorting to price cuts to fill seats (bottom panel), which will drag on profitability. Importantly, future capacity increases signal that deflation will remain a prominent industry theme for the foreseeable future, and act as a weight on valuation multiples. Stick with a high-conviction underweight. The ticker symbols for the stocks in this index are: AAL, DAL, LUV, UAL.

Special Report

Headline and aggregate-economy statistics such as GDP and income are no longer representative statistics for the living standards of the vast majority of the population. This <i>Special Report</i> discusses the implications for politics, economics and investment.

Two weeks ago we outlined our top ten reasons to deemphasize the tech sector in equity portfolios. The tech sector is experiencing a productivity drain that is threatening profit margins and return on equity. However, within the sector there is one positive exception to this view: communications equipment (CE). Investment in CE is climbing relative to total investment and compared with IT investment after a prolonged slump. Years of underinvestment suggest that some pent-up demand has been created, allowing for the potential to outperform even if overall capital spending continues to sink, as we expect. The main CE demand driver has been the telecom services sector. Telecom capital spending has increased significantly, as measured by telecom facilities construction. That leads CE industry top-line growth, signaling revenue expansion ahead (bottom panel). Domestic demand strength has been partially offset by weak global markets. A strong U.S. dollar has undermined U.S. telecom equipment exports at the same time that foreign demand growth, China's imports in particular, has faltered. Still, global headwinds are more than discounted, as the relative forward P/E trades at a massive discount, even though industry productivity is improving. Bottom Line: re-rating potential exists despite our overall economic and broad market concerns. The ticker symbols for the stocks in this index are: CSCO, FFIV, HRS, JNPR, MSI.

While the communications equipment industry provides a contrarian tech sector investment opportunity, in relative terms, computer hardware offers a much different profile. Hardware investment is highly cyclical, rising and falling with discretionary spending budgets. The latter are being pruned as the corporate sector tightens its belt as a consequence of deflation and profit margin pressure. The chart shows that, unlike telecom equipment, hardware investment continues to sink as a share of total spending. That will sustain downward sales pressure and keep manufacturers operating at suboptimal rates. Already, the rate of hardware output has plunged, and is well below the rate of capacity growth. Such a dynamic warns of an intensification of deflationary pressures, particularly given that vendors to end clients are aggressively slashing prices. Without a positive demand impulse, the odds of computer hardware profit disappointment will remain acute. We continue to recommend an underweight position. The ticker symbols for the stocks in this index are: AAPL, EMC, HPE, HPQ, NTAP, SNDK, STX, WDC.